![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » TANABE SEIYAKU LAUNCHES NEW ANTI-RHEUMATIC
TANABE SEIYAKU LAUNCHES NEW ANTI-RHEUMATIC
Tanabe Seiyaku launched Methotrexate tablets 2 mg TANABE (generic name: methotrexate), an anti-rheumatic drug for the indication of rheumatoid arthritis (RA) only if there is no indication of improvement when conventional treatment therapies such as nonsteroidal anti-inflammatory agents and other anti-rheumatic agents are used.
JCN Network (http://www.japancorp.net/Article.Asp?Art_ID=12929)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct